VBI Poised To Take On GSK, Dynavax As Hep B Vaccination Market Takes Off

 
• By Joseph Haas
  
Hepatitis B
VBI Vaccines hopes to take on entrenched competitors with a new HBV vaccine
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip